Cargando…
siRNA Knockdown of RRM2 Effectively Suppressed Pancreatic Tumor Growth Alone or Synergistically with Doxorubicin
Pancreatic cancer is currently one of the deadliest of the solid malignancies, whose incidence and death rates are increasing consistently during the past 30 years. Ribonucleotide reductase (RR) is a rate-limiting enzyme that catalyzes the formation of deoxyribonucleotides from ribonucleotides, whic...
Autores principales: | Zheng, Shuquan, Wang, Xiaoxia, Weng, Yu-Hua, Jin, Xingyu, Ji, Jia-Li, Guo, Liangxia, Hu, Bo, Liu, Nan, Cheng, Qiang, Zhang, Jianqi, Bai, Huicheng, Yang, Tongren, Xia, Xin-Hua, Zhang, Hong-Yan, Gao, Shan, Huang, Yuanyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118156/ https://www.ncbi.nlm.nih.gov/pubmed/30153565 http://dx.doi.org/10.1016/j.omtn.2018.08.003 |
Ejemplares similares
-
Synergistic treatment of osteosarcoma with biomimetic nanoparticles transporting doxorubicin and siRNA
por: Zhao, Jingtong, et al.
Publicado: (2023) -
Systemic Administration of siRNA via cRGD-containing Peptide
por: Huang, Yuanyu, et al.
Publicado: (2015) -
Pharmacokinetic Behaviors of Intravenously Administered siRNA in Glandular Tissues
por: Huang, Yuanyu, et al.
Publicado: (2016) -
Therapeutic siRNA: state of the art
por: Hu, Bo, et al.
Publicado: (2020) -
The pH-Triggered Triblock Nanocarrier Enabled Highly Efficient siRNA Delivery for Cancer Therapy
por: Du, Lili, et al.
Publicado: (2017)